Health Law & Life Sciences Practice Group Partner Michael Manthei will be speaking at CBI's 5th Annual Medical Device and Diagnostic Marketing Compliance Congress. The conference will focus on actionable strategic risk-management practices and supply attendees with critical enforcement updates. Mr. Manthei's program is titled, "Control Off-Label Promotion Liability Risks and Examine Revised Guidance Impact on Industry." He and a representative of Salient Surgical Technologies will be discussing the following:
The event will be held at the Westin Arlington Gateway in Arlington, VA from June 15-16, 2009.
Please note that email communications to the firm through this website do not create an attorney-client relationship between you and the firm. Do not send any privileged or confidential information to the firm through this website. Click "accept" below to confirm that you have read and understand this notice.